Disseminated intravascular coagulation in obstetric disorders and its acute haematological management

被引:138
作者
Thachil, Jecko [1 ]
Toh, Cheng-Hock [1 ,2 ]
机构
[1] Univ Liverpool, Royal Liverpool Univ Hosp, Sch Clin Sci, Liverpool L69 3GA, Merseyside, England
[2] Royal Liverpool Univ Hosp, Rd Dahl Haemostasis & Thrombosis Ctr, Liverpool, Merseyside, England
基金
英国医学研究理事会;
关键词
Coagulation; Disseminated intravascular coagulation; Fibrinolysis; Obstetrics; Placenta; Pregnancy; Thrombin; ACTIVATED PROTEIN-C; FACTOR PATHWAY INHIBITOR; RECOMBINANT FACTOR VIIA; ACUTE FATTY LIVER; NORMAL-PREGNANCY; PLACENTAL ABRUPTION; TISSUE FACTOR; FIBRINOLYSIS INHIBITOR; FIBRINOGEN CONCENTRATE; POSTPARTUM HEMORRHAGE;
D O I
10.1016/j.blre.2009.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As activation of the coagulation pathway is a physiological response to injury, the development of dis-seminated intravascular coagulation (DIC) is a warning signal to the clinician that the primary pathological disease state is decompensating. In pregnancy, DIC can occur in several settings, which include emergencies such as placental abruption and amniotic fluid embolism as well as complications such as pre-eclampsia. Whilst the acuteness of the event and the proportionality in the coagulant and fibrinolytic responses may vary between these different conditions, a common theme for pregnancy-associated DIC is the pivotal role played by the placenta. Removal of the placenta is the linchpin to treatment in most cases but appropriate blood product support is also key to management. This is necessary because DIC itself can have pathological consequences that translate clinically into a worse prognosis for affected patients. This article will describe how pregnancy-associated DIC can be diagnosed promptly and how treatment should be managed strategically. It also discusses the latest developments in Our understanding of haemostatic mechanisms within the placenta and how these may have relevance to new diagnostic approaches as well as novel therapeutic modalities. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 115 条
[1]   Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis [J].
Aharon, A ;
Brenner, B ;
Katz, T ;
Miyagi, Y ;
Lanir, N .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (04) :776-786
[2]   Placental abruption in term and preterm gestations - Evidence for heterogeneity in clinical pathways [J].
Ananth, Cande V. ;
Getahun, Darios ;
Peltier, Morgan R. ;
Smulian, John C. .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (04) :785-792
[3]  
[Anonymous], 1901, AM J OBSTET GYNECOL
[4]  
Antovic JP, 2002, THROMB HAEMOSTASIS, V88, P644
[5]   Acute fatty liver of pregnancy [J].
Bacq, Y .
SEMINARS IN PERINATOLOGY, 1998, 22 (02) :134-140
[6]  
Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959
[7]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[8]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[9]  
Boffa MC, 1998, THROMB HAEMOSTASIS, V79, P1092
[10]   ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES [J].
BOISCLAIR, MD ;
IRELAND, H ;
LANE, DA .
BLOOD REVIEWS, 1990, 4 (01) :25-40